Dynamic Contrast-Enhanced Perfusion Processing for Neuroradiologists: Model-Dependent Analysis May Not Be Necessary for Determining Recurrent High-Grade Glioma versus Treatment Effect

被引:17
作者
Hamilton, J. D. [1 ,4 ]
Lin, J. [2 ,5 ,6 ]
Ison, C. [1 ]
Leeds, N. E. [1 ]
Jackson, E. F. [2 ]
Fuller, G. N. [3 ]
Ketonen, L. [1 ]
Kumar, A. J. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Sect Neuroimaging, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Sect MRI Phys, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Sect Neuropathol, Houston, TX 77030 USA
[4] Radiol Partners Houston, Houston, TX 77040 USA
[5] Rice Univ, Houston, TX USA
[6] Baylor Coll Med, Houston, TX 77030 USA
关键词
CEREBRAL BLOOD-VOLUME; RADIATION-INJURY; INDUCED NECROSIS; BRAIN; LEAKAGE; TRIALS;
D O I
10.3174/ajnr.A4190
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: Dynamic contrast-enhanced perfusion MR imaging has proved useful in determining whether a contrast-enhancing lesion is secondary to recurrent glial tumor or is treatment-related. In this article, we explore the best method for dynamic contrast-enhanced data analysis. MATERIALS AND METHODS: We retrospectively reviewed 24 patients who met the following conditions: 1) had at least an initial treatment of a glioma, 2) underwent a half-dose contrast agent (0.05-mmol/kg) diagnostic-quality dynamic contrast-enhanced perfusion study for an enhancing lesion, and 3) had a diagnosis by pathology within 30 days of imaging. The dynamic contrast-enhanced data were processed by using model-dependent analysis (nordicICE) using a 2-compartment model and model-independent signal intensity with time. Multiple methods of determining the vascular input function and numerous perfusion parameters were tested in comparison with a pathologic diagnosis. RESULTS: The best accuracy (88%) with good correlation compared with pathology (P = .005) was obtained by using a novel, model-independent signal-intensity measurement derived from a brief integration beginning after the initial washout and by using the vascular input function from the superior sagittal sinus for normalization. Modeled parameters, such as mean endothelial transfer constant > 0.05 minutes(-1), correlated (P = .002) but did not reach a diagnostic accuracy equivalent to the model-independent parameter. CONCLUSIONS: A novel model-independent dynamic contrast-enhanced analysis method showed diagnostic equivalency to more complex model-dependent methods. Having a brief integration after the first pass of contrast may diminish the effects of partial volume macroscopic vessels and slow progressive enhancement characteristic of necrosis. The simple modeling is technique- and observer-dependent but is less time-consuming.
引用
收藏
页码:686 / 693
页数:8
相关论文
共 21 条
[1]   The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme [J].
Ballman, Karla V. ;
Buckner, Jan C. ;
Brown, Paul D. ;
Giannini, Caterina ;
Flynn, Patrick J. ;
LaPlant, Betsy R. ;
Jaeckle, Kurt A. .
NEURO-ONCOLOGY, 2007, 9 (01) :29-38
[2]   Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging [J].
Barajas, Ramon F., Jr. ;
Chang, Jamie S. ;
Segal, Mark R. ;
Parsa, Andrew T. ;
McDermott, Michael W. ;
Berger, Mitchel S. ;
Cha, Soonmee .
RADIOLOGY, 2009, 253 (02) :486-496
[3]   Distinguishing Recurrent High-grade Gliomas from Radiation Injury: A Pilot Study Using Dynamic Contrast-enhanced MR Imaging [J].
Bisdas, Sotirios ;
Naegele, Thomas ;
Ritz, Rainer ;
Dimostheni, Artemisia ;
Pfannenberg, Christina ;
Reimold, Matthias ;
Koh, Tong San ;
Ernemann, Ulrike .
ACADEMIC RADIOLOGY, 2011, 18 (05) :575-583
[4]   T1- and T2*-dominant extravasation correction in DSC-MRI: Part I-theoretical considerations and implications for assessment of tumor hemodynamic properties [J].
Bjornerud, Atle ;
Sorensen, A. Gregory ;
Mouridsen, Kim ;
Emblem, Kyrre E. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2011, 31 (10) :2041-2053
[5]   Effect of bevacizumab on radiation necrosis of the brain [J].
Gonzalez, Javier ;
Kumar, Ashok J. ;
Conrad, Charles A. ;
Levin, Victor A. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (02) :323-326
[6]   Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements [J].
Hu, L. S. ;
Baxter, L. C. ;
Smith, K. A. ;
Feuerstein, B. G. ;
Karis, J. P. ;
Eschlbacher, J. M. ;
Coons, S. W. ;
Nakaji, P. ;
Yeh, R. F. ;
Debbins, J. ;
Heiserman, J. E. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2009, 30 (03) :552-558
[7]   Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging [J].
Jackson, Alan ;
O'Connor, James P. B. ;
Parker, Geoff J. M. ;
Jayson, Gordon C. .
CLINICAL CANCER RESEARCH, 2007, 13 (12) :3449-3459
[8]   Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy [J].
Kohshi, K ;
Imada, H ;
Nomoto, S ;
Yamaguchi, R ;
Abe, H ;
Yamamoto, H .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 209 (1-2) :115-117
[9]   Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment [J].
Kumar, AJ ;
Leeds, NE ;
Fuller, GN ;
Van Tassel, P ;
Maor, MH ;
Sawaya, RE ;
Levin, VA .
RADIOLOGY, 2000, 217 (02) :377-384
[10]   The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations [J].
Leach, MO ;
Brindle, KM ;
Evelhoch, JL ;
Griffiths, JR ;
Horsman, MR ;
Jackson, A ;
Jayson, GC ;
Judson, IR ;
Knopp, MV ;
Maxwell, RJ ;
McIntyre, D ;
Padhani, AR ;
Price, P ;
Rathbone, R ;
Rustin, GJ ;
Tofts, PS ;
Tozer, GM ;
Vennart, W ;
Waterton, JC ;
Williams, SR ;
Workmanw, P .
BRITISH JOURNAL OF CANCER, 2005, 92 (09) :1599-1610